COSCIENS Biopharma Inc. has seen notable fluctuations this week, closing at C$7.65 on Monday, reflecting a 3.38% increase over the past week.
COSCIENS Biopharma Inc. (CSCI.TO) has been in the spotlight this week following its recent financial disclosures. The stock closed at C$7.65 on Monday, marking a 0.53% gain for the day and a 3.38% rise over the past week. Investors are keen to understand the implications of the company's recent performance and market dynamics.
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeMarket cap
$9.15M
52W high
$14.80
52W low
$3.30
1W change
-0.76%
Beta
1.80
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
62.5%
Annualized
90-Day Vol
335.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.97
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.74 | C$7.85 – C$12.09 |
| 60 trading days | C$10.34 | C$7.62 – C$14.03 |
| 90 trading days | C$10.97 | C$7.56 – C$15.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider COSCIENS Biopharma's recent financial results and ongoing operational updates as they evaluate the stock's potential. The recent price action, coupled with the company's financial improvements, may offer insights into its future trajectory.
COSCIENS Biopharma's stock has appreciated 163.79% year-to-date.
The stock's impressive year-to-date performance reflects strong investor interest and confidence in the company's strategic direction, despite recent financial losses.
Bull case
The company reported a significant reduction in its net loss for Q2 2026 compared to the previous year, indicating improved operational efficiency and the potential for stronger future performance.
Bear case
Despite recent improvements, COSCIENS Biopharma has a high beta of 1.90, which means it is more volatile than the market. This could pose risks for investors.
Recent Price Action
COSCIENS Biopharma Inc. has experienced a positive trend this week, with its stock closing at C$7.65 on Monday. This reflects a 0.53% increase for the day and a 3.38% rise over the past week. Year-to-date, the stock has seen an impressive appreciation of 163.79%, indicating strong investor sentiment.
Financial Performance Insights
Advertisement
Recent headlines highlight COSCIENS Biopharma's financial results for Q2 2026, where the company reported a net loss of $0.2 million, a marked improvement from the $2.7 million loss in Q2 2025. This was attributed to higher gross margins and improved sales volumes. The company also provided updates following its reconstitution of the Board of Directors, underscoring its commitment to strategic growth.
Technical Picture
From a technical standpoint, COSCIENS Biopharma's stock is currently trading below both its 50-day moving average of C$8.89 and its 200-day moving average of C$20.02, indicating potential challenges in regaining upward momentum. The stock's 52-week range is C$3.30 – C$14.80, with the current price at approximately 38% of this range. The stock exhibits a beta of 1.90, suggesting higher volatility compared to the broader market. Notably, the recent trading volume of 1,952 shares is double the 20-day average of 977 shares, which may indicate growing investor interest.
Insider Activity
No significant insider activity has been reported recently for COSCIENS Biopharma Inc., which may suggest stability in management and strategic direction.
Conclusion
COSCIENS Biopharma Inc. closed at C$7.65, reflecting a daily increase of 0.53%. Investors should monitor the company's ongoing financial performance and market developments as they assess potential investment opportunities.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
